2023
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities
Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.Peer-Reviewed Original ResearchMeSH KeywordsAftercareHeart FailureHumansMaleMorbidityPatient DischargePatient ReadmissionRetrospective StudiesRisk FactorsPredictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis
Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.Peer-Reviewed Original ResearchMeSH KeywordsComorbidityHeart FailureHospitalizationHumansPatient ReadmissionRetrospective StudiesRisk FactorsConceptsElixhauser co-morbidity indexHeart failureMultivariate logistic regressionCo-morbiditiesSecondary diagnosisPatients admitted with HFPatient co-morbiditiesAdmitted with HFDetrimental to patientsPopulation of patientsLogistic regressionCo-morbidity indexReadmission riskDiagnosis of HFSecondary diagnosis of HFNationwide Readmissions DatabaseCo-morbid complicationsRenal failureComparing patientsShort-term rehospitalizationHF patientsStatistically significant predictorsPredicting 30-day readmissionIncreased riskElixhauser co-morbiditiesEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2018
Updates in heart failure 30-day readmission prevention
Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.Peer-Reviewed Original ResearchConceptsHospital Readmissions Reduction ProgramAffordable Care ActReduce health care costsReadmission ratesReduce short-term readmissionsReadmissions Reduction ProgramHF readmissionHealth care costsCare costsShort-term readmissionCare ActAdmission diagnosisPrevent heart failureReduction programsRemote hemodynamic monitoringReadmissionMedical therapyHeart failureHF patientsHemodynamic monitoringHospitalProgramImpaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease
Yeh D, Schmidt A, Eisman A, Serfas J, Naqvi M, Youniss M, Ryfa A, Khan A, Safi L, Tabtabai S, Bhatt A, Lewis G. Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease. Heart 2018, 104: 2044. PMID: 30030334, DOI: 10.1136/heartjnl-2017-312572.Peer-Reviewed Original ResearchConceptsCardiopulmonary exercise testingRV reserveRight ventricleHeart failureNew York Heart Association classPrimary composite clinical outcomeFirst-pass radionuclide ventriculographyPrevalence of heart failureRV ejection fractionRV systolic functionEvent-free survivalMedian follow-upCongenital heart diseaseReserve groupComposite clinical outcomeAdverse cardiac outcomesTertiary care centreRight ventricular reserveAdverse cardiovascular outcomesPredicting adverse cardiovascular outcomesSystolic function assessmentRV dilatationACHD populationPrognostic impactAsymptomatic patients
2017
Acoustic speech analysis of patients with decompensated heart failure: A pilot study
Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.Peer-Reviewed Original ResearchConceptsHeart failureIntracardiac filling pressuresDecompensated heart failureSpeech analysisIndicators of HFAcoustic speech analysisSpeech breathing characteristicsDiuretic treatmentPeripheral edemaPilot studyFilling pressureCreaky voiceSpeech passagesPatientsMonitoring patientsSpeech respirationSpeechIncreasing fundamental frequencyEdemaSustained vowelsAcoustic measurements
2016
National Trends in Hospitalizations of Adults With Tetralogy of Fallot
Schmidt A, Yeh D, Tabtabai S, Kennedy K, Yeh R, Bhatt A. National Trends in Hospitalizations of Adults With Tetralogy of Fallot. The American Journal Of Cardiology 2016, 118: 906-911. PMID: 27530825, PMCID: PMC5349299, DOI: 10.1016/j.amjcard.2016.06.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultArrhythmias, CardiacComorbidityCross-Sectional StudiesDatabases, FactualDiabetes MellitusEquipment FailureFemaleHeart FailureHeart Valve Prosthesis ImplantationHospital CostsHospital MortalityHospitalizationHumansHypertensionKidney DiseasesMaleMiddle AgedObesityPneumoniaPrevalencePulmonary ValveTetralogy of FallotUnited StatesYoung AdultConceptsTetralogy of FallotHigher quality of careCo-morbiditiesQuality of careFollow-up of patientsHealth care systemPrevalence of obesityModifiable risk factorsPrevalence of co-morbiditiesRates of co-morbiditiesUnited States Nationwide Inpatient SamplePulmonic valve replacementPrimary admission diagnosisHospitalizations of adultsPopulation of adultsNationwide Inpatient SampleCross-sectional dataCare systemDiagnostic codesValve replacementPrevention effortsHeart failureHospital admissionAdmission diagnosisFollow-up